Yrab-D 30mg/20mg Capsule SR
Marketer
VHVL Inc
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Yrab-D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) is effectively managed with Duo-Relief 30mg/20mg Extended-Release Capsules, a dual-action formulation. This medication targets heartburn, stomach upset, and irritation by both neutralizing stomach acid and facilitating gas expulsion for improved comfort. Duo-Relief should be taken on an empty stomach, following your physician's prescribed dosage and duration. Treatment length depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete disclosure of all other medications to your healthcare provider is crucial due to potential interactions. Common, generally transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects promptly. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to increased drowsiness risk. Lifestyle adjustments, such as consuming cool milk and avoiding caffeinated beverages, spicy foods, and chocolate, may enhance treatment outcomes. Pre-existing liver or kidney conditions, pregnancy, pregnancy planning, or breastfeeding should be discussed with your doctor before commencing Duo-Relief therapy.
Primary Ingredients of Yrab-D 30mg/20mg Capsule SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Yrab-D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Yrab-D 30mg/20mg Capsule SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire capsule without chewing, crushing, or fracturing it. Yrab-D 30mg/20mg Extended-Release Capsules should be taken on an empty stomach.
Common Side effects of Yrab-D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Yrab-D 30mg/20mg Capsule SR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Yrab-D 30mg/20mg Capsule SR whole; avoid chewing, crushing, or fracturing. Consume on an empty stomach.
How Yrab-D 30mg/20mg Capsule SR works:
Yrab-D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, two medications acting synergistically. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating improved food transit through the stomach. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Yrab-D 30mg/20mg SR Capsules with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The extended-release Yrab-D 30mg/20mg capsule might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Yrab-D 30mg/20mg capsule is likely not safe for breastfeeding mothers. Preliminary human evidence indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Yrab-D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Yrab-D 30mg/20mg sustained-release capsules cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Yrab-D 30mg/20mg sustained-release capsules cautiously, potentially requiring dosage modification. Consult your physician. Yrab-D 30mg/20mg sustained-release capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Yrab-D 30mg/20mg Capsule SR :
Should you forget a Yrab-D 30mg/20mg Capsule SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Yrab-D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |





